EP1941902A1 - Verwendung von Somatostatin Analogen zur Behandlung von Cluster Kopfschmerzen - Google Patents

Verwendung von Somatostatin Analogen zur Behandlung von Cluster Kopfschmerzen Download PDF

Info

Publication number
EP1941902A1
EP1941902A1 EP07100010A EP07100010A EP1941902A1 EP 1941902 A1 EP1941902 A1 EP 1941902A1 EP 07100010 A EP07100010 A EP 07100010A EP 07100010 A EP07100010 A EP 07100010A EP 1941902 A1 EP1941902 A1 EP 1941902A1
Authority
EP
European Patent Office
Prior art keywords
somatostatin
analog
srif
cluster headache
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP07100010A
Other languages
English (en)
French (fr)
Inventor
designation of the inventor has not yet been filed The
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to EP07100010A priority Critical patent/EP1941902A1/de
Priority to EP08701194A priority patent/EP2114439A1/de
Priority to CA002674186A priority patent/CA2674186A1/en
Priority to MX2009007188A priority patent/MX2009007188A/es
Priority to US12/521,191 priority patent/US20100069296A1/en
Priority to RU2009129597/15A priority patent/RU2009129597A/ru
Priority to AU2008203708A priority patent/AU2008203708B2/en
Priority to BRPI0806484-9A priority patent/BRPI0806484A2/pt
Priority to PCT/EP2008/050006 priority patent/WO2008081013A1/en
Publication of EP1941902A1 publication Critical patent/EP1941902A1/de
Priority to US13/226,837 priority patent/US20110319329A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
EP07100010A 2007-01-02 2007-01-02 Verwendung von Somatostatin Analogen zur Behandlung von Cluster Kopfschmerzen Ceased EP1941902A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
EP07100010A EP1941902A1 (de) 2007-01-02 2007-01-02 Verwendung von Somatostatin Analogen zur Behandlung von Cluster Kopfschmerzen
RU2009129597/15A RU2009129597A (ru) 2007-01-02 2008-01-02 Применение аналогов соматостатина при мигрени
CA002674186A CA2674186A1 (en) 2007-01-02 2008-01-02 Use of somatostatin analogs in cluster headache
MX2009007188A MX2009007188A (es) 2007-01-02 2008-01-02 Uso de analogos de somatostatina en cefalalgia histaminica.
US12/521,191 US20100069296A1 (en) 2007-01-02 2008-01-02 Use of somatostatin analogs in cluster headache
EP08701194A EP2114439A1 (de) 2007-01-02 2008-01-02 Verwendung von somatostatin-analogen bei cluster-kopfschmerzen
AU2008203708A AU2008203708B2 (en) 2007-01-02 2008-01-02 Use of somatostatin analogs in cluster headache
BRPI0806484-9A BRPI0806484A2 (pt) 2007-01-02 2008-01-02 uso de análogos de somatostatina em cefaléia em salvas
PCT/EP2008/050006 WO2008081013A1 (en) 2007-01-02 2008-01-02 Use of somatostatin analogs in cluster headache
US13/226,837 US20110319329A1 (en) 2007-01-02 2011-09-07 Use of somatostatin analogs in cluster headache

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07100010A EP1941902A1 (de) 2007-01-02 2007-01-02 Verwendung von Somatostatin Analogen zur Behandlung von Cluster Kopfschmerzen

Publications (1)

Publication Number Publication Date
EP1941902A1 true EP1941902A1 (de) 2008-07-09

Family

ID=37846227

Family Applications (2)

Application Number Title Priority Date Filing Date
EP07100010A Ceased EP1941902A1 (de) 2007-01-02 2007-01-02 Verwendung von Somatostatin Analogen zur Behandlung von Cluster Kopfschmerzen
EP08701194A Ceased EP2114439A1 (de) 2007-01-02 2008-01-02 Verwendung von somatostatin-analogen bei cluster-kopfschmerzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP08701194A Ceased EP2114439A1 (de) 2007-01-02 2008-01-02 Verwendung von somatostatin-analogen bei cluster-kopfschmerzen

Country Status (8)

Country Link
US (2) US20100069296A1 (de)
EP (2) EP1941902A1 (de)
AU (1) AU2008203708B2 (de)
BR (1) BRPI0806484A2 (de)
CA (1) CA2674186A1 (de)
MX (1) MX2009007188A (de)
RU (1) RU2009129597A (de)
WO (1) WO2008081013A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012302636B2 (en) * 2011-09-04 2016-09-15 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017037A1 (en) * 1992-02-21 1993-09-02 Sandoz Ltd. Treatment of acute migraine or cluster headache attacks
WO1997001579A2 (en) * 1995-06-29 1997-01-16 Novartis Ag Somatostatin peptides
WO2002010192A2 (en) * 2000-08-01 2002-02-07 Novartis Ag Somatostatin analogues
WO2005041901A2 (en) * 2003-11-03 2005-05-12 Elixir Pharmaceuticals, Inc. Therapeutics using somatostatin agonists

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017037A1 (en) * 1992-02-21 1993-09-02 Sandoz Ltd. Treatment of acute migraine or cluster headache attacks
WO1997001579A2 (en) * 1995-06-29 1997-01-16 Novartis Ag Somatostatin peptides
WO2002010192A2 (en) * 2000-08-01 2002-02-07 Novartis Ag Somatostatin analogues
WO2005041901A2 (en) * 2003-11-03 2005-05-12 Elixir Pharmaceuticals, Inc. Therapeutics using somatostatin agonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
M. S. MATHARU ET AL., ANN NEUROL,, vol. 56, 2004, pages 488 - 494, XP002426584 *

Also Published As

Publication number Publication date
AU2008203708B2 (en) 2011-12-01
BRPI0806484A2 (pt) 2011-09-27
RU2009129597A (ru) 2011-02-10
US20110319329A1 (en) 2011-12-29
US20100069296A1 (en) 2010-03-18
MX2009007188A (es) 2009-07-14
CA2674186A1 (en) 2008-07-10
AU2008203708A1 (en) 2008-07-10
WO2008081013A1 (en) 2008-07-10
EP2114439A1 (de) 2009-11-11

Similar Documents

Publication Publication Date Title
JP3255289B2 (ja) アルファー―２―アドレナリン作動薬及び成長ホルモン放出ペプチドによる肥満症の治療
EP1888094B1 (de) Amylin und amylinagonisten für die behandlung von psychiatrischen erkrankungen und störungen
US7485620B2 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
AU2006341375B2 (en) Amylin and amylin agonists for treating psychiatric diseases and disorders
JP5721624B2 (ja) 内因性高インスリン血症性低血糖症の治療のためのパシレオチドの使用
US9149510B2 (en) Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
US20110319329A1 (en) Use of somatostatin analogs in cluster headache
EP2224947B1 (de) Verwendung von somatostatin analoga zur behandlung von meningiomen
MX2008010141A (en) Combination of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20080726